Trials / Completed
CompletedNCT02194192
Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section
Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section; a Randomized, Double Blinded, Placebo Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Maternal hypotension after spinal anesthesia in parturients undergoing cesarean section is a very common problem leading to several complications to both patients and their babies. It can cause maternal discomfort, lightheadedness, nausea and vomiting. The most important complication is the decreasing blood flow to babies; which may lead to fetal acidosis. Many interventions has been studied in order to prevent hypotension after spinal anesthesia in cesarean section e.g., fluid loading: colloid vs crystalloid, medications: ephedrine, phenylephrine, and metaraminol, etc. The recent study showed ondansetron (the antiemetic drug) can be effectively used to prevent hypotension after spinal anesthesia in normal patients or parturients. The action of ondansetron is believed to inhibit Bezold-Jarish reflex. This aim of this study is to compare the efficacy of ephedrine and ondansetron in the prevention of maternal hypotension after spinal anesthesia in cesarean section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Normal saline 10 ml |
| DRUG | Ondansetron | Ondasetron 8 mg IV after spinal anesthesia |
| DRUG | Ephedrine | Ephedrine 10 mg IV after spinal anesthesia |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-07-18
- Last updated
- 2015-03-17
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02194192. Inclusion in this directory is not an endorsement.